Nanotecnoloxías aplicadas ao deseño de sistemas de liberación de fármacos
NANOBIOFAR
Instituto de Oftalmología Aplicada de Valladolid
Valladolid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Oftalmología Aplicada de Valladolid (10)
2018
-
Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation
International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30
-
Xanthan gum-functionalised span nanoparticles for gene targeting to endothelial cells
Colloids and Surfaces B: Biointerfaces, Vol. 170, pp. 411-420
2017
-
Designing lipid nanoparticles for topical ocular drug delivery
International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217
2014
-
Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing
International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20
2013
-
A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model
Gene Therapy, Vol. 20, Núm. 5, pp. 467-477
2011
-
Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles
Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788
-
Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells
Molecular Vision, Vol. 17, pp. 279-290
2010
-
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles
Cornea, Vol. 29, Núm. 5, pp. 550-558
2004
-
Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity
Pharmaceutical Research, Vol. 21, Núm. 5, pp. 803-810
2002
-
Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats
Current Eye Research, Vol. 24, Núm. 1, pp. 39-45